Evolent Health, Inc. (EVH)

Evolent Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-496.52	-534.51	-61.62	-113.04	-19.16	-37.6
Depreciation & Amortization	113.35	115.85	118.37	123.42	67.2	60.04
Stock-Based Compensation	39.31	39.74	39.75	40.5	33.98	16.71
Other Adjustments	20.4	475.15	38.83	69.81	13.38	22.09
Change in Receivables	85.22	73.7	32.06	-164.69	-102.98	-5.78
Changes in Accounts Payable	8.76	6.64	4.25	-6.72	13.17	7.25
Changes in Accrued Expenses	-36.83	-7.95	-62.51	5.47	-33.03	-6.04
Changes in Unearned Revenue	-3.6	-1.3	-3.47	-0.26	-6.51	-0.74
Changes in Other Operating Activities	-99.42	-128.47	-86.89	188.1	22.42	-17.18
Operating Cash Flow	33.29	38.84	18.77	142.58	-11.55	38.75
Operating Cash Flow Growth	80.74%	107.00%	-86.84%	-	-	-
Capital Expenditures	-31.9	-34.09	-24.89	-28.75	-38.36	-24.98
Purchases of Investments	-0.5	-1	-7.32	-	-	-3
Proceeds from Sale of Investments	-	-	-	-	-	0.5
Payments for Business Acquisitions	-52.95	-57.44	-30.73	-388.25	-248.11	-49.01
Proceeds from Business Divestments	-	91.31	-	0.58	-9.16	3.49
Other Investing Activities	0.59	0.99	0.01	0.87	36.52	57.21
Investing Cash Flow	6.45	-0.23	-62.93	-415.54	-259.12	-15.79
Long-Term Debt Issued	187.05	408.05	58.58	647.49	219.74	-
Long-Term Debt Repaid	280.48	342.98	-	464.2	-	98.85
Net Long-Term Debt Issued (Repaid)	467.53	751.03	58.58	1,112	219.74	98.85
Issuance of Common Stock	-	-	3.46	12.52	4.45	13.29
Repurchase of Common Stock	2.45	45.22	15.7	15.29	18.32	3.85
Net Common Stock Issued (Repurchased)	2.45	45.22	19.16	27.81	22.77	17.14
Issuance of Preferred Stock	-	-	-	168	-	-
Net Preferred Stock Issued (Repurchased)	-	-	-	168	-	-
Preferred Share Dividends Paid	-6.55	-11.13	-20.09	-18.79	-	-
Other Financing Activities	-4.82	-44.64	-26.82	-48.39	-74.33	59.86
Financing Cash Flow	-147.75	-35.92	-0.57	281.34	131.54	-29.55
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-1.1	-0.49	-0.23	-0.08	-0.66	-0.05
Net Cash Flow	-109.1	2.2	-44.96	8.3	-139.78	-6.64
Free Cash Flow	1.4	4.76	-6.13	113.84	-49.91	13.76
Free Cash Flow Growth	-70.66%	-	-	-	-	-
FCF Margin	0.07%	0.25%	-0.24%	5.80%	-3.69%	1.52%
Free Cash Flow Per Share	0.01	0.04	-0.05	1.02	-0.53	0.16
Levered Free Cash Flow	-115.89	122.31	-90.02	1,251	225.45	79.59
Unlevered Free Cash Flow	-468.18	-459.37	-94.72	241.49	25.97	-24.75

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q